Nobel-winning UK scientist launches programme to develop hepatitis C vaccine in Hong Kong
新聞摘要
以下為來源提供的節錄，完整報道請查看原文。
A British Nobel-winning virologist has launched a programme to develop the world’s first hepatitis C vaccine after joining a university in Hong Kong, tapping the city’s research funding, access to Chinese strains of the virus and partnerships with mainland drug makers.